Helix BioMedix (HXBM) Inactive 10-Q2011 Q1 Quarterly report

Filed: 5 May 11, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: accelerate, accelerated, Additionally, April, blended, cancelled, chapter, check, coupled, deemed, departure, Deposit, Drug, efficacy, electronically, enhance, extend, filer, Food, fourth, frequency, gain, greater, hand, impairment, Interactive, licensee, longer, mark, maximum, medical, mixture, past, performance, portfolio, post, posted, preceding, pursue, recoverable, registrant, Regulation, regulatory, Rule, Scientific, select, shell, shorter, site, smaller, specialty, specific, study, temporary, tender, TRANSITION, usage, variance, volume, Web, weighted

Removed: accredited, accreted, administered, agreement, allocate, annum, anticipation, arrangement, array, ASU, attributed, automatically, bankruptcy, bear, beginning, behalf, call, called, campaign, Cardinal, charge, closely, collaborative, combined, commercialize, consolidation, Court, credit, customer, default, delivered, determined, director, discounted, earlier, ecommerce, embedded, entered, entity, establish, established, event, evidence, expensed, expire, FASB, fee, forward, Frank, free, furnished, furnishing, goal, hold, holder, immaterial, improve, incorporated, influence, instrument, intellectual, invoiced, January, June, likelihood, line, lower, made, maturity, member, merger, monthly, Nickell, objective, October, offering, ongoing, paid, partnering, penalty, permitted, power, practicable, prepay, present, prevailing, prospectively, public, put, Qualitative, Quantitative, RBFSC, reclassification, reflecting, repayment, requirement, resale, restricted, separately, September, settlement, sheet, stated, subsequently, substantially, terminated, TPE, transaction, transparency, Treasurer, undelivered, unpaid, Update, voluntarily, voting, VSOE, warrant, wide

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

HXBM similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION OF ACTING CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350

I, R. Stephen Beatty, Acting Chief Financial Officer of Helix BioMedix, Inc. (the “Company”), certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 5, 2011


	/s/ R. Stephen Beatty
	R. Stephen Beatty Acting Chief Financial Officer